Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
Text Size
20 studies found for:    Open Studies | "Carcinoma, Small Cell"

Modify this search | How to Use Search Results

Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Cancel
Rank Status Study
1 Recruiting Paclitaxel and Nortriptyline Hydrochloride in Treating Patients With Relapsed Small Cell Carcinoma
Condition: Small Cell Carcinoma
Interventions: Drug: Nortriptyline Hydrochloride;   Drug: Paclitaxel
2 Recruiting Neurocognitive Function After Prophylactic Cranial Irradiation & Hippocampal Sparing in LD SCLC Patients - a Pilot Study
Condition: Carcinoma, Small Cell
Intervention: Radiation: Whole brain radiotherapy with reduced dose to the hippocampi
3 Recruiting TIvantinib as Maintenance Treatment in Extended Small-cell Lung Cancer (TIMES)
Condition: Carcinoma, Small Cell
Intervention: Drug: ARQ197
4 Recruiting HS-WBRT for Prophylactic Cranial Irradiation in Limited Stage Small Cell Lung Cancer
Condition: Carcinoma, Small Cell Lung
Interventions: Radiation: HS-WBRT PCI;   Radiation: Conventional PCI
5 Not yet recruiting Hypofractionated vs. Conventionally Fractionated Concurrent CRT for LD-SCLC
Conditions: Carcinoma, Small Cell;   Lung Neoplasms
Interventions: Radiation: hypofractionated concurrent chemoradiotherapy;   Radiation: conventionally fractionated concurrent chemoradiotherapy
6 Not yet recruiting Comparable Study of Different Thoracic Radiotherapy Regimens for Extensive Stage Small Cell Lung Cancer
Conditions: Carcinoma, Small Cell;   Lung Neoplasms
Interventions: Radiation: high-dose TRT;   Radiation: standard-dose TRT
7 Recruiting A Study to Assess Programmed Death Ligand-1 (PD-L1) Expression in Cytological Versus Histological Lung Cancer Specimens
Conditions: Carcinoma, Non-Small-Cell Lung;   Carcinoma, Small Cell
Interventions: Diagnostic Test: PD-L1 Immunocytochemistry (ICC);   Diagnostic Test: PD-L1 Immunohistochemistry (IHC)
8 Recruiting Metabolomic Analysis of Lung Cancer
Conditions: Carcinoma, Non-Small Cell Lung;   Carcinoma, Small Cell Lung
Intervention: Other: 13-C-glucose
9 Recruiting Tissue Procurement and Natural History Study of People With Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Extrapulmonary Small Cell Cancer, Pulmonary Neuroendocrine Tumors, and Thymic Epithelial Tumors
Conditions: Non-Small Cell Lung Cancer;   Small Cell Lung Cancer;   Extrapulmonary Small Cell Cancer;   Pulmonary Neuroendocrine Tumors;   Thymic Epithelial Tumors
Intervention:
10 Recruiting Prophylactic Cranial Irradiation (PCI) for Small Cell Carcinoma of the Urothelium
Condition: Bladder Cancer
Interventions: Radiation: Prophylactic Cranial Irradiation (PCI);   Other: Brain X-ray
11 Recruiting Trial of Topotecan With VX-970, an ATR Kinase Inhibitor, in Small Cell Cancers
Conditions: Carcinoma, Non-Small -Cell Lung;   Ovarian Neoplasms;   Small Cell Lung Carcinoma;   Uterine Cervical Neoplasms;   Carcinoma, Neuroendocrine
Interventions: Drug: Topotecan;   Drug: VX-970
12 Recruiting Molecular Profiling and Targeted Therapy for Advanced Non-Small Cell Lung Cancer, Small Cell Lung Cancer, and Thymic Malignancies
Conditions: Carcinoma, Non-Small-Cell Lung;   Carcinoma, Small Cell Lung;   Carcinoma, Thymic
Interventions: Drug: AZD6244;   Drug: MK-2206;   Drug: Lapatinib;   Drug: Erlotinib;   Drug: Sunitinib;   Procedure: Molecular Profiling
13 Recruiting International Ovarian & Testicular Stromal Tumor Registry
Conditions: Ovarian Stromal Tumor;   Testicular Stromal Tumors;   Ovarian Small Cell Carcinoma
Intervention:
14 Not yet recruiting Study of Apatinib as Third-line and Later Therapy in Patients With Small Cell Lung Cancer (SCLC)
Condition: Small Cell Lung Cancer
Intervention: Drug: Apatinib Mesylate tablet
15 Recruiting PEN-221 in Somatostatin Receptor 2 Expressing Advanced Cancers Including Neuroendocrine and Small Cell Lung Cancers
Conditions: Neuroendocrine Tumors;   Carcinoma, Small Cell Lung;   Carcinoma, Large Cell Lung;   Merkel Cell Carcinoma;   Pheochromocytoma;   Paraganglioma;   Thyroid Cancer, Medullary;   Neuroendocrine Carcinoma
Intervention: Drug: PEN-221
16 Recruiting Circulating Tumor DNA in Patients at High Risk for Lung Cancer
Conditions: Cancer of the Lung;   Lung Cancer;   Lung Neoplasms;   Adenocarcinoma of the Lung;   Non Small Cell Carcinoma of the Lung;   Small Cell Carcinoma of the Lung
Intervention:
17 Recruiting Olaparib With or Without Cediranib in Treating Patients With Metastatic Castration-Resistant Prostate Cancer
Conditions: Castration Levels of Testosterone;   Castration-Resistant Prostate Carcinoma;   Metastatic Prostate Carcinoma;   Prostate Adenocarcinoma With Focal Neuroendocrine Differentiation;   Prostate Carcinoma Metastatic in the Bone;   Prostate Small Cell Carcinoma;   PSA Progression;   Stage IV Prostate Adenocarcinoma
Interventions: Drug: Cediranib;   Other: Laboratory Biomarker Analysis;   Drug: Olaparib
18 Recruiting Durvalumab+/- Tremelimumab in Combination With Platinum Based Chemotherapy in Untreated Extensive-Stage Small Cell Lung Cancer (Caspian)
Condition: Small Cell Lung Carcinoma Extensive Disease
Interventions: Drug: Durvalumab;   Drug: Tremelimumab;   Drug: Carboplatin;   Drug: Cisplatin;   Drug: Etoposide
19 Recruiting A Phase II, Study to Determine the Preliminary Efficacy of Novel Combinations of Treatment in Patients With Platinum Refractory Extensive-Stage Small-Cell Lung Cancer
Condition: Platinum Refractory Extensive-Stage Small Cell Lung Carcinoma
Interventions: Drug: Durvalumab and Tremelimumab;   Drug: AZD1775 and carboplatin (CBPT)
20 Recruiting Use of Social Networking to Survey Women With Small and Large Cell Carcinomas of the Cervix
Condition: Cervical Cancer
Intervention: Behavioral: Questionnaires
To Top

† Study has passed its completion date and status has not been verified in more than two years.